Alexander Zverev is competing in his first-ever Wimbledon final since making his debut in the competition in 2015, facing men ...

For years, researchers investigating insulin as a potential Alzheimer’s treatment have faced a frustrating pattern: promising ...

University of Wisconsin researchers and collaborators recently published a feasibility study that focuses on limiting fetal growth restriction in nonhuman primates through nanoparticle injections of ...

India, July 13 -- With Alexander Zverev being a Type 1 Diabetic and receiving special exemption from the stakeholders to use ...

Why did Alexander Zverev take an injection during Wimbledon final? - The French Open champion has a medical exemption needs ...

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food ...

An insulin inhaler proved safe for treating children as young as 4 years old, improving satisfaction and reducing weight gain ...

LONDON (AP) — Alexander Zverev has more than just defending champion Jannik Sinner to deal with on Sunday in the Wimbledon ...

As the weight-loss pill hits the market, users report subtly different side effects from the injections ...

Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...

A North Carolina woman says she was prescribed a weight-loss drug from a telehealth company and suffered a GLP-1 overdose ...

Nicotinamide adenine dinucleotide (NAD) and its reduced form (NADH) therapy are dietary supplements that are promoted widely ...